Related Experiment Video

Updated: May 23, 2026

RhoC GTPase Activation Assay
09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

The cellular functions of RASSF1A and its inactivation in prostate cancer

Karishma S Amin1, Partha P Banerjee

  • 1Department of Biochemistry and Molecular and Cellular Biology, Georgetown University Medical Center, Washington DC, USA.

Journal of Carcinogenesis
|March 23, 2012
PubMed

Insights

Ras-association domain family 1 isoform A (RASSF1A) is a tumor suppressor gene silenced in many cancers. Restoring RASSF1A function may offer a promising therapeutic strategy for prostate cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • Epigenetic silencing of the RASSF1A tumor suppressor gene, often via promoter hypermethylation, is common in various human cancers.
  • RASSF1A loss-of-function contributes to uncontrolled cell proliferation by affecting cell cycle progression and apoptosis.
  • While RASSF1A's tumor-suppressive role is established, the precise mechanisms underlying its function require further elucidation.

Purpose of the Study:

  • To review the current understanding of RASSF1A's biological functions.
  • To explore the molecular mechanisms through which RASSF1A mediates tumor suppression.
  • To highlight the therapeutic potential of restoring RASSF1A function, particularly in prostate cancer.

Main Methods:

  • Literature review of studies on RASSF1A function and epigenetic silencing.
  • Analysis of molecular interactions involving RASSF1A in cell cycle regulation, apoptosis, and microtubule stability.
  • Synthesis of evidence regarding RASSF1A's role in various cancer types.

Main Results:

  • RASSF1A regulates microtubule stability, cell cycle progression, and apoptosis induction.
  • Loss of RASSF1A function results in accelerated cell cycling and resistance to apoptosis.
  • Re-expression of RASSF1A can reverse the cancerous phenotype in experimental models.

Conclusions:

  • RASSF1A plays a critical role in maintaining cellular homeostasis and suppressing tumor development.
  • Targeted therapies aimed at restoring RASSF1A function represent a potential avenue for cancer treatment.
  • Further research into RASSF1A's molecular pathways could unlock novel therapeutic strategies for prostate cancer.
Keywords:
Epigenetic silencingRASSF1Aprostate cancer

More Related Videos

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...